about
Targeting Immune Regulatory Networks to Counteract Immune Suppression in CancerTumor-Derived Exosomes and Their Role in Tumor-Induced Immune SuppressionTumor-Related Exosomes Contribute to Tumor-Promoting Microenvironment: An Immunological Perspective.Extracellular vesicles: masters of intercellular communication and potential clinical interventions.Current Perspectives on In Vivo Noninvasive Tracking of Extracellular Vesicles with Molecular Imaging.Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe.Roles of exosomes in the normal and diseased eye.Dendritic cell-derived exosomes for cancer therapy.Exosomes: novel implications in diagnosis and treatment of gastrointestinal cancer.Myeloid-derived suppressor cells and tumor escape from immune surveillance.Going live with tumor exosomes and microvesicles.The role of pancreatic cancer-derived exosomes in cancer progress and their potential application as biomarkers.The emerging roles of tumor-derived exosomes in hematological malignancies.Exosomes carrying immunoinhibitory proteins and their role in cancer.Engineering exosomes as refined biological nanoplatforms for drug delivery.Targeting adenosine in cancer immunotherapy: a review of recent progress.Tuning cancer fate: the unremitting role of host immunity.Exosomes and Other Extracellular Vesicles in HPV Transmission and Carcinogenesis.Atg9b Deficiency Suppresses Autophagy and Potentiates Endoplasmic Reticulum Stress-Associated Hepatocyte Apoptosis in Hepatocarcinogenesis.Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathwayRoles and Modalities of Ectonucleotidases in Remodeling the Multiple Myeloma Niche.Not all extracellular vesicles were created equal: clinical implications.Engineering of extracellular vesicles as drug delivery vehicles.Saliva exosomes from pancreatic tumor-bearing mice modulate NK cell phenotype and antitumor cytotoxicity.Role of LFA-1 and ICAM-1 in Cancer.Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment.Clinical significance of PD-L1+ exosomes in plasma of Head and Neck Cancer patients.The effect of tumor-derived exosomes on immune regulation and cancer immunotherapy.Tumor-derived exosomes educate dendritic cells to promote tumor metastasis via HSP72/HSP105-TLR2/TLR4 pathway.New Technologies for Analysis of Extracellular Vesicles.Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.Response commentary: exosomes vs microvesicles in hematological malignancies.Exosomes in Cancer: Another Mechanism of Tumor-Induced Immune Suppression.14-3-3ζ delivered by hepatocellular carcinoma-derived exosomes impaired anti-tumor function of tumor-infiltrating T lymphocytes.Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246.Suppression of Lymphocyte Functions by Plasma Exosomes Correlates with Disease Activity in Patients with Head and Neck Cancer.Exosomal microRNA predicts and protects against severe bronchopulmonary dysplasia in extremely premature infants.Potential roles of tumor-derived exosomes in angiogenesis.Exosomes in Nasopharyngeal Carcinoma.The Double Face of Exosome-Carried MicroRNAs in Cancer Immunomodulation.
P2860
Q28066486-5BCDC65E-41D4-4DE5-A07F-66C9FF690C07Q28076769-2DB28716-ABBB-4376-BA2C-D67863750BB6Q33795061-1F8BBD02-256E-48B8-9712-6CBA36D328EFQ36737922-D17DF1BF-B7CB-480D-B655-FA2FB41A3814Q37637322-1DBA7F42-4203-4BF6-B50D-AB9D4063BF26Q38600659-6013777D-1BC0-472D-9380-55ED704B7AE5Q38688358-70ADCB46-71C3-4144-BFC8-537716DE53A6Q38795623-FAD42003-1FF3-467C-8F21-B3C8182FCEB1Q38876434-175041F1-F46F-4FCE-99CA-2CD29F5952EFQ38992562-9E13B3A8-46CC-4D90-BF5E-9D4575347DFDQ39109745-543048FB-D51B-4A7B-9DFF-2AC571A3F73FQ39123707-3414CA06-678F-4ED2-9560-065CFD5A92F3Q39188856-C5C10DCF-1328-4431-A130-396095AC7B40Q39215663-200B7403-5AA6-44DD-A774-5B7CEFB312A4Q39230414-2C9FA8ED-D783-4CFD-AC45-DEBFCA75A086Q39235260-761223E8-46D2-4BC1-963B-94D488086D97Q39239026-BC6D98E2-5C05-4EE3-89F1-D6FED87637CDQ40092337-B7A78536-35A8-457C-A72D-F2FDC0468336Q40980450-7B9797C2-9F45-4DD8-8620-D08A89760396Q41472760-EAB9BAAB-7D63-4777-B0F4-BFB8A91D17AFQ41959993-7A27342B-42D5-413A-84B2-F47CD5AA57F1Q42314918-42254299-533B-400B-9430-F6B7ED950864Q46311969-0A4D9826-7729-4875-A5BA-A7CDC302BED1Q46751395-BF8A03F1-DD05-43CF-876B-8BF83DC829A6Q47106562-3FAF242A-96F6-4391-838A-E1286DC64C6CQ47242698-FF47808F-7465-4EE0-AE4A-6149985E92BAQ47256356-47645E53-E765-49AC-9143-4885AF3802E1Q47337961-4CE897D5-62BE-4C6A-9F10-5AEDE8D72345Q47689335-775B7193-5D9F-47BA-AA1B-1CED6CF33D73Q48135155-19366210-537B-4026-938C-349C19EB159BQ48293607-65CAE307-037A-478A-BE11-6C1C863077A3Q49406745-C12087ED-16F2-4234-8F4F-321AA68CDE0AQ49592892-958C0DEF-4617-40E2-BB54-FCDA23426260Q50054912-9FB95752-1C7E-4999-975B-7004E01F18CFQ50322440-F1C61B88-A8A0-43D7-AB4E-7C90F2572B47Q51063063-4238071E-9B20-47F8-B8DC-90F33C409A66Q51743308-81FC43E3-A7FA-4620-905F-8C964C6EAC2DQ52326601-37A66137-3703-418E-9DCE-215F9E09ABA3Q52340925-BCE9FBC9-1C51-4688-836A-3AF4AB62F8C1Q52589944-AE4B8262-FA0D-4B25-8059-EF48BB9F46C2
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Exosomes and tumor-mediated immune suppression.
@ast
Exosomes and tumor-mediated immune suppression.
@en
type
label
Exosomes and tumor-mediated immune suppression.
@ast
Exosomes and tumor-mediated immune suppression.
@en
prefLabel
Exosomes and tumor-mediated immune suppression.
@ast
Exosomes and tumor-mediated immune suppression.
@en
P2860
P356
P1476
Exosomes and tumor-mediated immune suppression.
@en
P2093
Theresa L Whiteside
P2860
P304
P356
10.1172/JCI81136
P407
P577
2016-02-29T00:00:00Z